PARIS, FRANCE: Assystem S.A. has signed an agreement to sell its life sciences and general industry technical assistance businesses to Expleo Group.
The enterprise value agreed between the parties is €28 million and the deal is scheduled to close on January 1, 2022.
The agreement covers Assystem Care France, Assystem Belgium and Assystem Care Switzerland as well as two French going concerns (fonds de commerce).
The revenue generated in 2021 by these divested businesses is expected to approximate €39 million.
As a result of this agreement – which means that the divested businesses will be deconsolidated as of January 1, 2021 in accordance with IFRS 5 – Assystem’s consolidated revenue and EBITA margin for full-year 2021 are now expected to come in at around €480 million and 6.4% respectively.
Also in accordance with IFRS 5, the Group management costs that were previously allocated to the divested businesses will be deemed to be borne by the remaining entities in Assystem’s scope of consolidation. The estimated net effect on the Group’s 2021 EBITA margin of deconsolidating the divested businesses and reallocating these Group management costs is a negative 0.2 points.
Assystem is an international engineering group. As a key participant in the industry for over 50 years, the Group supports its clients in managing their capital expenditure throughout their asset life cycles. Assystem S.A. is listed on Euronext Paris. www.assystem.com